Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-12-08

Clinical Trial Update: Compassionate Use of Omegaven IV Fat Emulsion

View source ↗

Summary

Compassionate-use access to Omegaven IV fat emulsion for cholestasis and liver disease is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omegaven IV Fat Emulsion (omega-3 fatty acid lipid emulsion)

Snippet

Sponsor: Northwell Health | Conditions: Cholestasis, Liver Disease | Status: NO_LONGER_AVAILABLE